- Home
- VNDA vs ELLO Comparison
VNDA vs ELLO Comparison
Compare VNDA & ELLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VNDA
- ELLO
- Stock Information
- Founded
- VNDA 2002
- ELLO 1987
- Country
- VNDA United States
- ELLO Israel
- Employees
- VNDA N/A
- ELLO N/A
- Industry
- VNDA Biotechnology: Pharmaceutical Preparations
- ELLO Electric Utilities: Central
- Sector
- VNDA Health Care
- ELLO Utilities
- Exchange
- VNDA Nasdaq
- ELLO Nasdaq
- Market Cap
- VNDA 249.4M
- ELLO 232.0M
- IPO Year
- VNDA 2006
- ELLO 1995
- Fundamental
- Price
- VNDA $4.75
- ELLO $17.30
- Analyst Decision
- VNDA Strong Buy
- ELLO
- Analyst Count
- VNDA 2
- ELLO 0
- Target Price
- VNDA $16.50
- ELLO N/A
- AVG Volume (30 Days)
- VNDA 551.9K
- ELLO 4.3K
- Earning Date
- VNDA 07-31-2025
- ELLO 09-29-2025
- Dividend Yield
- VNDA N/A
- ELLO N/A
- EPS Growth
- VNDA N/A
- ELLO N/A
- EPS
- VNDA N/A
- ELLO 0.43
- Revenue
- VNDA $203,467,000.00
- ELLO $44,405,534.00
- Revenue This Year
- VNDA $16.86
- ELLO N/A
- Revenue Next Year
- VNDA $39.78
- ELLO N/A
- P/E Ratio
- VNDA N/A
- ELLO $44.60
- Revenue Growth
- VNDA 11.78
- ELLO N/A
- 52 Week Low
- VNDA $3.81
- ELLO $11.30
- 52 Week High
- VNDA $5.55
- ELLO $20.81
- Technical
- Relative Strength Index (RSI)
- VNDA 60.39
- ELLO 47.70
- Support Level
- VNDA $4.47
- ELLO $16.72
- Resistance Level
- VNDA $4.88
- ELLO $18.26
- Average True Range (ATR)
- VNDA 0.16
- ELLO 0.77
- MACD
- VNDA 0.05
- ELLO -0.15
- Stochastic Oscillator
- VNDA 82.43
- ELLO 30.56
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.
About ELLO Ellomay Capital Ltd (Israel)
Ellomay Capital Ltd is a renewable energy company. It develops and operates renewable energy projects in Europe, the USA, and Israel, employing diverse technologies such as solar power, natural gas, pumped hydro, and waste-to-energy solutions.